PAPedro Ming Azevedo

Pedro Ming Azevedo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Pedro Ming Azevedo has a total of 66 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Impact of Different Onboarding Strategies on Low Adoption and Engagement With a Self-Monitoring and Management App for Chronic Musculoskeletal Pain: Prospective Study

    by Cinja Nadana Koller, Marc Blanchard, Johanna Mettler, Tiffany Prétat, Pedro Ming Azevedo, Thomas Hügle

    Background: Suboptimal adoption and engagement rates of digital health applications present challenges to their effectiveness, particularly in chronic disease management such as fibromyalgia. Up to half of patients do not download the prescribed digital health applications or actively engage with them, making effective onboarding a critical opportunity for improvement. Objective: We aimed to investigate the impact of 3 different patient onboarding strategies on adoption, adherence, and engagement with a digital health application for the symptom management of chronic pain syndromes. Methods: We conducted a 4-week nonrandomized prospective study comprising patients (aged ≥18 years) with chronic musculoskeletal pain who fulfilled the fibromyalgia criteria and were using a new self-monitoring and management application after onboarding. The pain organizer and companion system consists of symptom reporting, symptom monitoring, and an advice and exercise section. Participants in group 1 (standard) received an email-based onboarding with detailed instructions on application download, registration, use, usability data capture, data security, and study procedures without any in-person assistance. Group 2 (video) received the same email plus a video tutorial explaining the application’s use also without any in-person assistance. Group 3 (assisted) underwent an enhanced in-person onboarding, which included hands-on support for application setup and guided instructions from a health care professional. Primary outcomes included adoption, engagement, and adherence, measured respectively by successful application download with at least 1 log-in, cumulative activations, and connection at least once per week over 4 weeks. Results: A total of 48 patients were recruited (mean age 45.7, SD 12.2; range 19-79 years). In the assisted group, all 15 participants in the assisted onboarding group downloaded the application compared to 63% (10/16) in the standard group and 77% (13/17) in the video group. A significant difference in adoption between the in-person onboarding group (group 3) and the remote groups (groups 1 and 2) with P=.009 was observed. Overall engagement, measured by cumulative app activation, ranged between 0 and 28 log-ins, with no significant difference (P=.18) in mean log-ins across the 3 groups. Overall adherence was low with 27% (13/48) of participants meeting adherence criteria and a retention rate of 46% (22/48) at week 4. Responses to the System Usability Scale survey were limited to 8 responses but achieved a score of 70.31, indicating good usability of the application. Conclusions: Unassisted downloading and account creation might be barriers to adopting a digital health app among patients with chronic musculoskeletal pain.


  • Open Access

    Impact of Different Onboarding Strategies on Low Adoption and Engagement With a Self-Monitoring and Management App for Chronic Musculoskeletal Pain: Prospective Study (Preprint)

    by Cinja Nadana Koller, Marc Blanchard, Johanna Mettler, Tiffany Prétat, Pedro Ming Azevedo, Thomas Hügle

    BACKGROUND Suboptimal adoption and engagement rates of digital health applications present challenges to their effectiveness, particularly in chronic disease management such as fibromyalgia. Up to half of patients do not download the prescribed digital health applications or actively engage with them, making effective onboarding a critical opportunity for improvement. OBJECTIVE We aimed to investigate the impact of 3 different patient onboarding strategies on adoption, adherence, and engagement with a digital health application for the symptom management of chronic pain syndromes. METHODS We conducted a 4-week nonrandomized prospective study comprising patients (aged ≥18 years) with chronic musculoskeletal pain who fulfilled the fibromyalgia criteria and were using a new self-monitoring and management application after onboarding. The pain organizer and companion system consists of symptom reporting, symptom monitoring, and an advice and exercise section. Participants in group 1 (standard) received an email-based onboarding with detailed instructions on application download, registration, use, usability data capture, data security, and study procedures without any in-person assistance. Group 2 (video) received the same email plus a video tutorial explaining the application’s use also without any in-person assistance. Group 3 (assisted) underwent an enhanced in-person onboarding, which included hands-on support for application setup and guided instructions from a health care professional. Primary outcomes included adoption, engagement, and adherence, measured respectively by successful application download with at least 1 log-in, cumulative activations, and connection at least once per week over 4 weeks. RESULTS A total of 48 patients were recruited (mean age 45.7, SD 12.2; range 19-79 years). In the assisted group, all 15 participants in the assisted onboarding group downloaded the application compared to 63% (10/16) in the standard group and 77% (13/17) in the video group. A significant difference in adoption between the in-person onboarding group (group 3) and the remote groups (groups 1 and 2) with P=.009 was observed. Overall engagement, measured by cumulative app activation, ranged between 0 and 28 log-ins, with no significant difference (P=.18) in mean log-ins across the 3 groups. Overall adherence was low with 27% (13/48) of participants meeting adherence criteria and a retention rate of 46% (22/48) at week 4. Responses to the System Usability Scale survey were limited to 8 responses but achieved a score of 70.31, indicating good usability of the application. CONCLUSIONS Unassisted downloading and account creation might be barriers to adopting a digital health app among patients with chronic musculoskeletal pain.

  • Open Access

    Clinical predictors of immediate response to a multimodal inpatient programme for chronic refractory musculoskeletal pain syndromes—a cross-sectional study

    by Tiffany Pretat, Thomas Hügle, Johanna Mettler, Marc Suter, Sandy Jean-Scherb, Pedro Ming-Azevedo

    Objectives: Chronic pain (CP) affects approximately 20% of the global population, leading to significant disability and economic burden. Multimodal programmes (MMPs) are the most effective short-term interventions for managing musculoskeletal chronic pain syndromes (MCPS). However, patient characteristics influence treatment response, requiring personalized approaches. This study aims to identify clinical, social and psycho-behavioural predictors of immediate response to a 2-week inpatient MMP for refractory MCPS. Methods: A cross-sectional study analysed 207 MCPS patients who completed an MMP at CHUV Lausanne, Switzerland, from March 2018 to November 2022. Validated questionnaires assessed pain severity, impact, kinesiophobia, catastrophizing and other factors before and after the programme. Univariate and multivariate analyses identified predictors of treatment response. Results: Significant improvements were observed in 9 out of 12 outcomes, including pain severity (P = 0.01), pain impact (P < 0.01), disability (P = 0.14), kinesiophobia (P<0.001) and catastrophizing (P < 0.001). Non-specific low-back pain, catastrophizing at entry, biomechanical disorders and psychiatric conditions were identified as key predictors of treatment response, respectively influencing 4, 3, 3 and 2 over 9 outcome measures in multivariable analysis. Non-specific low-back pain was linked to worse outcomes, whereas reductions in catastrophizing correlated with improved pain severity and kinesiophobia. Socioeconomic factors, such as disputes over disability financial aid, also influenced outcomes. Conclusion: This study confirms a modest yet significant immediate benefit of MMP for patients with refractory MCPS and provided a deeper insight into the predictors of treatment outcomes and their influence on various outcome measures. Further longitudinal studies are needed to confirm these findings and explore underlying mechanisms.


  • Open Access

    Patients with refractory musculoskeletal pain syndromes undergoing a multimodal assessment and therapy programme: a cross-sectional study

    by Tiffany Prétat, Thomas Hügle, Johanna Mettler, Marc Suter, Sandy Jean Scherb, Reine-Laure Taily, Charlotte Hans, Marielle Hoarau, Laurent Monod, Pierre Frossard, et al.

    BACKGROUND: Chronic musculoskeletal pain syndromes, including fibromyalgia, are heterogeneous entities with a major socioeconomic burden. Multimodal treatment programmes have shown greater efficacy than conventional approaches for these patients, at least in the short term. A profound understanding of chronic musculoskeletal pain syndrome patients treated in multimodal treatment programmes is important for their development and to provide insight into these conditions. AIM: To provide a comprehensive and objective description of medical, psychosocial and sleep characteristics of the treatment-refractory chronic musculoskeletal pain syndrome patients treated at the multimodal treatment programmes provided by our tertiary service in Switzerland. METHODS: This was a cross-sectional analysis of 202 refractory chronic musculoskeletal pain syndrome patients with or without a concomitant autoimmune disorder hospitalised between 2018 and 2022 in a 12-day Swiss multimodal treatment programme. They underwent a comprehensive self-assessment with eight different questionnaires and assessments by a psychiatrist, rheumatologist, pain specialist, occupational therapist and physiotherapist. Sleep assessment was performed via actigraphy. Clinical and demographic variables were selected by consensus of three experienced rheumatologists and chronic pain specialists. The Fibromyalgia Rapid Screening Test (FiRST), American College of Rheumatology (ACR)-2010 criteria (ACR2010) and Toronto Alexithymia Scale-20 (TAS-20) were also applied. RESULTS: The mean age of the patients was 47 years (SD = 10), 73% were female, and 30% were obese. Half (50%) were not from Switzerland, and 12% came from conflict zones. Almost half (40%) lived alone. Back pain was the principal site (90%). Of the patients, 78% fulfilled the ACR2010 criteria for fibromyalgia, and 17% were diagnosed with an underlying immune-mediated disorder, mostly spondylarthritis. Pain since childhood occurred in 45% of the patients, and 68% had pain since adolescence. Disability financial aid had been pursued by 69%, and 46% were still awaiting a response. Psychiatric comorbidities were highly prevalent (73%), of which 56% consisted of depression. Of all patients, 15% were diagnosed with enduring personality changes after a catastrophic experience (EPCACE), and 10% had post-traumatic stress disorder. Alexithymia affected 34% of patients. Objective sleep disorder was observed in 78% of patients, and 41% were under opioid therapy. CONCLUSION: This analysis reveals the complex psychosomatic and socioeconomic patterns of the patients treated in Switzerland with refractory chronic musculoskeletal pain syndromes, often originating in childhood and adolescence. Obesity, immigration, social isolation, psychiatric comorbidities, sleep deprivation and opiate use, among others, stood out as target characteristics for further research.


  • Open Access

    Development of a Management App for Postviral Fibromyalgia-Like Symptoms: Patient Preference-Guided Approach

    by Marc Blanchard, Cinja Nadana Koller, Pedro Ming Azevedo, Tiffany Prétat, Thomas Hügle

    Background: Persistent fibromyalgia-like symptoms have been increasingly reported following viral infections, including SARS-CoV-2. About 30% of patients with post–COVID-19 syndrome fulfill the fibromyalgia criteria. This complex condition presents significant challenges in terms of self-management. Digital health interventions offer a viable means to assist patients in managing their health conditions. However, the challenge of ensuring their widespread adoption and adherence persists. This study responds to this need by developing a patient-centered digital health management app, incorporating patient preferences to enhance usability and effectiveness, ultimately aiming to improve patient outcomes and quality of life. Objective: This research aims to develop a digital health self-management app specifically for patients experiencing postviral fibromyalgia-like symptoms. By prioritizing patient preferences and engagement through the app’s design and functionality, the study intends to facilitate better self-management practices and improve adherence. Methods: Using an exploratory study design, the research used patient preference surveys and usability testing as primary tools to inform the development process of the digital health solution. We gathered and analyzed patients’ expectations regarding design features, content, and usability to steer the iterative app development. Results: The study uncovered crucial insights from patient surveys and usability testing, which influenced the app’s design and functionality. Key findings included a preference for a symptom list over an automated chatbot, a desire to report on a moderate range of symptoms and activities, and the importance of an intuitive onboarding process. While usability testing identified some challenges in the onboarding process, it also confirmed the importance of aligning the app with patient needs to enhance engagement and satisfaction. Conclusions: Incorporating patient feedback has been a significant factor in the development of the digital health app. Challenges encountered with user onboarding during usability testing have highlighted the importance of this process for user adoption. The study acknowledges the role of patient input in developing digital health technologies and suggests further research to improve onboarding procedures, aiming to enhance patient engagement and their ability to manage digital health resources effectively. International Registered Report Identifier (IRRID): RR2-10.2196/32193


  • Open Access

    Development of a Management App for Postviral Fibromyalgia-Like Symptoms: Patient Preference-Guided Approach (Preprint)

    by Marc Blanchard, Cinja Nadana Koller, Pedro Ming Azevedo, Tiffany Prétat, Thomas Hügle

    BACKGROUND Persistent fibromyalgia-like symptoms have been increasingly reported following viral infections, including SARS-CoV-2. About 30% of patients with post–COVID-19 syndrome fulfill the fibromyalgia criteria. This complex condition presents significant challenges in terms of self-management. Digital health interventions offer a viable means to assist patients in managing their health conditions. However, the challenge of ensuring their widespread adoption and adherence persists. This study responds to this need by developing a patient-centered digital health management app, incorporating patient preferences to enhance usability and effectiveness, ultimately aiming to improve patient outcomes and quality of life. OBJECTIVE This research aims to develop a digital health self-management app specifically for patients experiencing postviral fibromyalgia-like symptoms. By prioritizing patient preferences and engagement through the app’s design and functionality, the study intends to facilitate better self-management practices and improve adherence. METHODS Using an exploratory study design, the research used patient preference surveys and usability testing as primary tools to inform the development process of the digital health solution. We gathered and analyzed patients’ expectations regarding design features, content, and usability to steer the iterative app development. RESULTS The study uncovered crucial insights from patient surveys and usability testing, which influenced the app’s design and functionality. Key findings included a preference for a symptom list over an automated chatbot, a desire to report on a moderate range of symptoms and activities, and the importance of an intuitive onboarding process. While usability testing identified some challenges in the onboarding process, it also confirmed the importance of aligning the app with patient needs to enhance engagement and satisfaction. CONCLUSIONS Incorporating patient feedback has been a significant factor in the development of the digital health app. Challenges encountered with user onboarding during usability testing have highlighted the importance of this process for user adoption. The study acknowledges the role of patient input in developing digital health technologies and suggests further research to improve onboarding procedures, aiming to enhance patient engagement and their ability to manage digital health resources effectively. INTERNATIONAL REGISTERED REPORT RR2-10.2196/32193

  • Open Access

    An mHealth App for Fibromyalgia-like Post–COVID-19 Syndrome: Protocol for the Analysis of User Experience and Clinical Data

    by Marc Blanchard, Lars Backhaus, Pedro Ming Azevedo, Thomas Hügle

    Background: Post–COVID-19 syndrome, also referred as “long covid,” describes persisting symptoms after SARS-CoV-2 infection, including myalgia, fatigue, respiratory, or neurological symptoms. Objective symptoms are often lacking, thus resembling a fibromyalgia-like syndrome. Digital therapeutics have shown efficiency in similar chronic disorders such as fibromyalgia, offering specific disease monitoring and interventions such as cognitive behavioral therapy or physical and respiratory exercise guidance. Objective: This protocol aims to study the requirements and features of a new mobile health (mHealth) app among patients with fibromyalgia-like post–COVID-19 syndrome in a clinical trial. Methods: We created a web application prototype for the post–COVID-19 syndrome called “POCOS,” as a web-based rehabilitation tool aiming to improve clinical outcomes. Patients without organ damage or ongoing inflammation will be included in the study. App use will be assessed through user experience questionnaires, focus groups, and clinical data analysis. Subsequently, we will analyze cross-sectional and longitudinal clinical data. Results: The developed mHealth app consists of a clinically adapted app interface with a simplified patient-reported outcome assessment, monitoring of medical interventions, and disease activity as well as web-based instructions for specific physical and respiratory exercises, stress reduction, and lifestyle instructions. The enrollment of participants is expected to be carried out in November 2021. Conclusions: User experience plays an important role in digital therapeutics and needs to be clinically tested to allow further improvement. We here describe this process for a new app for the treatment of the fibromyalgia-like post–COVID-19 syndrome and discuss the relevance of the potential outcomes such as natural disease course and disease phenotypes. International Registered Report Identifier (IRRID): PRR1-10.2196/32193


  • Open Access

    An mHealth App for Fibromyalgia-like Post–COVID-19 Syndrome: Protocol for the Analysis of User Experience and Clinical Data (Preprint)

    by Marc Blanchard, Lars Backhaus, Pedro Ming Azevedo, Thomas Hügle

    BACKGROUND Post–COVID-19 syndrome, also referred as “long covid,” describes persisting symptoms after SARS-CoV-2 infection, including myalgia, fatigue, respiratory, or neurological symptoms. Objective symptoms are often lacking, thus resembling a fibromyalgia-like syndrome. Digital therapeutics have shown efficiency in similar chronic disorders such as fibromyalgia, offering specific disease monitoring and interventions such as cognitive behavioral therapy or physical and respiratory exercise guidance. OBJECTIVE This protocol aims to study the requirements and features of a new mobile health (mHealth) app among patients with fibromyalgia-like post–COVID-19 syndrome in a clinical trial. METHODS We created a web application prototype for the post–COVID-19 syndrome called “POCOS,” as a web-based rehabilitation tool aiming to improve clinical outcomes. Patients without organ damage or ongoing inflammation will be included in the study. App use will be assessed through user experience questionnaires, focus groups, and clinical data analysis. Subsequently, we will analyze cross-sectional and longitudinal clinical data. RESULTS The developed mHealth app consists of a clinically adapted app interface with a simplified patient-reported outcome assessment, monitoring of medical interventions, and disease activity as well as web-based instructions for specific physical and respiratory exercises, stress reduction, and lifestyle instructions. The enrollment of participants is expected to be carried out in November 2021. CONCLUSIONS User experience plays an important role in digital therapeutics and needs to be clinically tested to allow further improvement. We here describe this process for a new app for the treatment of the fibromyalgia-like post–COVID-19 syndrome and discuss the relevance of the potential outcomes such as natural disease course and disease phenotypes. INTERNATIONAL REGISTERED REPORT PRR1-10.2196/32193

  • Open Access

    The Brazillian version of the hand mobility in scleroderma (HAMIS) test: translation and validation

    by Pedro Ming Azevedo, Estefânia Sartorato Sanson, Thelma Larocca Skare, Thiago Alberto Fernandes Gomes dos Santos, Patricia Martin

    Background: The Hand Mobility in Scleroderma (HAMIS) test was created to measure the degree of dysfunction of hand movements imposed by systemic sclerosis (SSc). The modified version (mHAMIS), with 4 of the 9 original items, was developed later. The goal of the present study was to translate and validate HAMIS and mHAMIS into Brazilian Portuguese and culture. Methods: After direct and reverse translation and comprehension test in 10 SSc patients, HAMIS-Br was applied to another 32 patients with SSc. To evaluate internal consistency, intraobserver and interobserver agreement, and intraobserver and interobserver reliability, we used respectively the Cronbach’s α coefficient, kappa concordance and intraclass correlation (ICC). The correlation between HAMIS-Br and mHAMIS-Br was evaluated and a factorial analysis was performed. Results: HAMIS-Br showed excellent internal consistency (Cronbach’s α = 0.997), good intraobserver agreement (kappa between 0.78 [95%CI =0.57–0.99] and 1) and intraobserver and interobserver reliability (ICC = 0.993, 95% CI = 0.973–0.993 and ICC = 0.994, 95% CI = 0.987–0.997, respectively). The mHAMIS-Br presented similar results and excellent correlation with HAMIS-Br (r = 0.923). The factorial analysis extracted three groups of questions that explain 84.4% of the total variance, and that can be understood through the influence of certain movements in the interpretation of others: [1] questions whose interpretation is influenced by the extension of the fingers, [2] questions whose interpretation is influenced by flexion of the fingers, [3] volar flexion of the fingers, with similar correlation with both other factors. Conclusions: HAMIS-Br and mHAMIS-Br showed good agreement, intraobserver and interobserver reliability, and internal validity. It is necessary to be attentive to the influence of certain limitations of movements in the interpretation of others.